9-FLUORO-11,21-DIHYDROXY-16-METHYL-17-((1-OXOPENTYL)OXY)PREGNANE-3,20-DIONE, (5.BETA.,11.BETA.,16.BETA.)-
UNII 40B174HC2M
Substance Identification & Data
This profile provides standardized clinical and technical data for 9-fluoro-11,21-dihydroxy-16-methyl-17-((1-oxopentyl)oxy)pregnane-3,20-dione, (5.beta.,11.beta.,16.beta.)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 40B174HC2M.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 80163-90-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C27H41FO6 BODNSZUVOINEPG-XFUDVEFMSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 9-fluoro-11,21-dihydroxy-16-methyl-17-((1-oxopentyl)oxy)pregnane-3,20-dione, (5.beta.,11.beta.,16.beta.)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.